SapeikaN.: The Excretion of Drugs in Human Milk — A Review, J. Obstet. Gynaecol. Br. Emp.54: 426–431 (Aug.) 1947.
2.
BurnJ. H.: Excretion of Drugs in Milk, Br. Med. Bull.5: 190–192, 1947–1948.
3.
IllingworthR. S.: Abnormal Substances Excreted in Human Milk, Practitioner171: 533–538 (Nov.) 1953.
4.
KnowlesJ. A.: Excretion of Drugs in Milk — A Review, J. Pediat.66: 1068–1082 (June) 1965.
5.
MatrangaA.: Drugs Excreted in Breast Milk, Drug Information Service Newsletter, Alta Bates Community Hospital2: 22–30 (May) 1970.
6.
TakyiB. E.: Excretion of Drugs in Human Milk, J. Hosp. Pharm.28: 317–326 (Nov.) 1970.
7.
ArenaJ. M.: Contamination of the Ideal Food, Nutr. Today5: 2–8 (Winter) 1970.
8.
ShoreM. F.: Drugs Can Be Dangerous During Pregnancy and Lactations (sic), Can. Pharm. J.103: 358–367 (Dec.) 1970.
9.
CatzC. S.GiacoiaG. P.: Drugs and Breast Milk, Pediatr. Clin. N. Am.19: 151–166 (Feb.) 1972.
10.
KnowlesJ. A.: Drugs in Milk, Pediatr. Currents21: 28–32, Ross Laboratories (Apr.) 1972.
11.
KnowlesJ. A.: Breast Milk: A Source of More than Nutrition for the Neonate, Clin. Toxicol.7: 69–82, 1974.
12.
Anon: Drugs in Breast Milk, Med. Letter16: 25–27 (Mar. 15) 1974.
13.
O'BrienT. E.: Excretion of Drugs in Human Milk, Am. J. Hosp. Pharm.31: 844–854 (Sept.) 1974.
14.
LevinR. H.: Teratogenicity and Drug Excretion in Breast Milk (Maternogenicity), in HerfindalE.T.HirschmanJ.L. (Eds.) Clinical Pharmacy and Therapeutics, Williams and Wilkins, Baltimore, 1975, pp. 23–44.
15.
VorherrH.: Drug Excretion in Breast Milk, Postgrad. Med.56: 97–104 (Oct.) 1974.
16.
SavageR. L.: Drugs and Breast Milk, Adverse Drug React. Bull. Number 61: 212–215 (Dec.) 1976.
17.
HorningM. G.: Identification and Quantification of Drugs and Drug Metabolites in Human Breast Milk Using GC-MS-COM Methods, Mod. Prob. Pediatr.15: 73–79, S. Karger, Basel, 1975.
18.
LienE. J.: Diffusion of Drugs into Prostatic Fluid and Milk, Drug Intell. Clin. Pharm.8: 470–475 (Aug.) 1974.
19.
AMA Council on Drugs: Penicillin and Other Antibiotics in Milk, J. Am. Med. Assoc.171: 49–51 (Sept. 5) 1959.
20.
LohmeyerH.HalfpapE.: Pharmakokinetische Untersuchungen und Klinisch Erfahrungen mit Ampicillin bei der Behandlung von Infektionen des Urogenitaltrakts der Frau, Z. Geburtsh. Gynaekol.164: 184–202 (Oct.) 1965.
21.
GreeneH. J.: Excretion of Penicillin in Human Milk Following Parturition, Am. J. Obstet. Gynecol.51: 732–733 (May) 1946.
22.
RozanskyR.BrezezinskyA.: The Excretion of Penicillin in Human Milk, J. Lab. Clin. Med.34: 497–500 (Apr.) 1949.
23.
Anon: Tetracycline in Breast Milk, Br. Med. J.4: 791 (Dec. 27) 1969.
24.
GuilbeauJ. A.: Aureomycin in Obstetrics: Therapy and Prophylaxis, J. Am. Med. Assoc.143: 520–526 (June 10) 1950.
25.
Von KobyletzkiD.StrauchD: Zur Frage der Diaplazentaren Passage und Ausscheidung mit der Muttermilch von Demethylchlortetracyclin, Z. Geburtsh. Gynäkol.161: 292–305 (Jan.) 1964.
26.
MorgantiG.: Comparative Concentrations of a Tetracycline Antibiotic in Serum and Maternal Milk, Antibiotica6: 216–223 (Sept.) 1968.
27.
BrogdenR. N.: Minocycline: A Review, Drugs9: 251–291, 1975.
28.
PosnerA. C.: Further Observations on the Use of Tetracycline Hydrochloride in Prophylaxis and Treatment of Obstetric Infections, Antibiot. Ann.1954–1955: 594–598.
29.
HarleyJ. D.RobinH.: “Late” Neonatal Jaundice Following Maternal Treatment with Sulfamethoxypyridazine, Pediatrics37: 855–856 (May) 1966.
30.
SparrR. A.PritchardJ. A.: Maternal and Newborn Distribution of Sulfamethoxypyridazine (Kynex®), Obstet. Gynecol.12: 131–134 (Aug.) 1958.
31.
SoaresR.: Da Concentração e Eliminação da Cloroquina Através da Circulação Placentária e do Leite Materno, de Pacientes sob Regime do Sal Cloroquinado, Rev. Brasil. Malariol. Doen. Trop.9: 19–27, 1957.
32.
MerlandR.CresteM.: Recherche de l'Élimination de la Nivaquine et son Dosage dans le Lait de Femme, Med. Tropicale11: 793–795 (Sept.-Oct.) 1951.
33.
ClydeD. F.: Transfer of Pyramethamine in Human Milk, J. Trop. Med. Hyg.59: 277–284 (Nov.) 1956.
34.
ClydeD. F.: Prolonged Malaria Prophylaxis through Pyramethamine in Mother's Milk, E. Afr. Med. J.37: 659–660, 1960. Abs. per Excerpta Medica 16.7:66 (Abs. #313) 1962.
35.
TerwilligerW. G.HatcherR. A.: The Elimination of Morphine and Quinine in Human Milk, Surg. Gynecol. Obstet.58: 823–826 (May) 1934.
36.
BergerH.: Excretion of Mandelic Acid in Breast Milk, Am. J. Dis. Child.61: 256–261 (Feb.) 1941.
37.
BeltonE. M.JonesR. V.: Hemolytic Anemia Due to Nalidixic Acid, Lancet2: 691 (Oct. 2) 1965.
38.
HosbachR. E.FosterR. B.: Absence of Nitrofurantoin from Human Milk, J. Am. Med. Assoc.202: 1057 (Dec. 11) 1967.
39.
VarsanoI.: The Excretion of Orally Ingested Nitrofurantoin in Human Milk, J. Pediatr.82: 886–887 (May) 1973.
40.
HavelkaJ.FrankovaA.: Study of Side Effects of Maternal Chloramphenicol Therapy in Newborns, Cesk. Pediatr.21: 31–33, 1972. Abstract per Excerpta Medica 27.7: 258–259 (Abs. #1577) 1972.
41.
SmadelJ. E.: Chloramphenicol (Chloromycetin®) in the Treatment of Tsutsugamushi Disease (Scrub Thyphus), J. Clin. Invest.28: 1196–1215 (Sept.) 1949.
42.
ProcházkaJ.: Excretion of Chloramphenicol in Human Milk. I, Čas Lék. Česk.103: 378–380, 1964. Abstract per Excerpta Medica 19.7:470 (Abs. #2349) 1965.
43.
HavelkaJ.: Excretion of Chloramphenicol in Human Milk, Chemotherapy13: 204–211, 1968.
44.
SmithJ. A.: Clindamycin in Human Breast Milk, Can. Med. Assoc. J.112: 806 (Apr. 5) 1975.
45.
MortonR. F.: Studies on the Absorption, Diffusion and Excretion of Cycloserine, Antibiot. Ann.1955–1956: 169–172.
46.
MedinaA.: Absorption, Diffusion and Excretion of a New Antibiotic, Lincomycin, Antimicrob. Agents Chemother.1963: 189–196.
47.
ChyoN.: Clinical Studies of Kanamycin Applied in the Field of Obstetrics and Gynecology, Asian Med. J.5: 265–275 (June) 1962.
48.
GrayM. S.: Further Observations on Metronidazole (Flagyl®), Br. J. Vener. Dis.37: 278–279 (Dec.) 1961.
49.
ArnauldR.: Étude du Passage de la Trimétho-prime dans le Lait Maternel, Ouest Med.25: 959–964 (Apr.) 1972.
50.
LevineW. G.: Anticoagulant, Antithrombotic and Thrombolytic Drugs, in GoodmanL. S.GilmanA. (Eds.), The Pharmacological Basis of Therapeutics, 5th Ed., Macmillan Publishing Co., New York, 1975, p. 1353.
51.
BrambelC. E.HunterR. E.: Effect of Dicumarol on the Nursing Infant, Am. J. Obstet. Gynecol.59: 1153–1159 (May) 1950.
52.
IllingworthR. S.FinchE.: Ethyl Biscoumacetate (Tromexan®) in Human Milk, J. Obstet. Gynaecol. Br. Commonw.66: 487–488 (June) 1959.
GoguelM.: Thérapeutique Anticoagulante et Allaitement: Étude du Passage de la Phényl-2-dioxo, 1,3 indane dans le Lait Maternel, Rev. Français Gynecol. Obstet.65: 409–412 (July-Aug.) 1970.
55.
WiernikP. H.DuncanJ. H.: Cyclophosphamide in Human Milk, Lancet1: 912 (May 1) 1971.
56.
JohnsD. G.: Secretion of Methotrexate into Human Milk, Am. J. Obstet. Gynecol.112: 978–980 (Apr. 1) 1972.
57.
PutterJ.: Quantitative Analysis of the Main Metabolites of Acetylsalicylic Acid. Comparative Analysis in the Blood and Milk of Lactating Women, Z. Geburtsh. Perinatol.178: 135–138, 1974. Abstract per Int. Pharm. Abstr. 12:320 (Abs. #1982) (Jan. 30) 1975.
58.
KwitN. T.HatcherR. A.: Excretion of Drugs in Milk, Am. J. Dis. Child.49: 900–904 (Apr.) 1935.
59.
BuchananR. A.: The Breast Milk Excretion on (sic) Flufenamic Acid, Curr. Ther. Res.11: 533–538 (Aug.) 1969.
60.
CobrinikR. W.: The Effect of Maternal Narcotic Addiction on the Newborn Infant, Pediatrics24: 288–304 (Aug.) 1959.
61.
BuchananR. A.: The Breast Milk Excretion of Mefenamic Acid, Curr. Ther. Res.10: 592–596 (Nov.) 1968.
62.
BlinickG.: Methadone Assays in Pregnant Women and Progeny, Am. J. Obstet. Gynecol.121: 617–621 (Mar. 1) 1975.
63.
KesäniemiY. A.: Ethanol and Acetaldehyde in the Milk and Peripheral Blood of Lactating Women after Ethanol Administration, J. Obstet. Gynaecol. Br. Commonw.81: 84–86 (Jan.) 1974.
64.
CoboE.: Effect of Different Doses of Ethanol on the Milk-Ejecting Reflex in Lactating Women, Am. J. Obstet. Gynecol.115: 817–821 (Mar. 15) 1973.
65.
TysonR. M.: Drugs Transmitted Through Breast Milk II. Barbiturates, J. Pediatr.14: 86–90 (July) 1938.
66.
TysonR. M.: Drugs Transmitted Through Breast Milk III. Bromides, J. Pediatr.14: 91–93 (July) 1938.
67.
van der BogertF.: Bromin (sic) Poisoning Through Mother's Milk, Am. J. Dis. Child.27: 167–169 (Feb.) 1921.
68.
PynnönenS.SillanpääM.: Carbamazepine and Mother's Milk, Lancet2: 563 (Sept. 20) 1975.
69.
BernstineJ. B.: Maternal Blood and Breast Milk Estimation Following the Administration of Chloral Hydrate During the Puerperium, J. Obstet. Gynaecol. Br. Emp.63: 228–231 (Apr.) 1956.
70.
LaceyJ. H.: Dichloralphenazone and Breast Milk, Br. Med. J.4: 684 (Dec. 11) 1971.
71.
PatrickM. J.: Diazepam and Breast-Feeding, Lancet1: 542–543 (Mar. 4) 1972.
72.
ErkkolaR.KantoJ.: Diazepam and Breast-Feeding, Lancet1: 1235–1236 (June 3) 1972.
73.
ColeA. P.HaileyD. M.: Diazepam and Active Metabolite in Breast Milk and their Transfer to the Neonate, Arch. Dis. Child.50: 741–742 (Sept.) 1975.
CurryS. H.: Disposition of Glutethimide in Man, Clin. Pharmacol. Ther.12: 849–857 (Sept.-Oct.) 1971.
77.
AydF. J.: Excretion of Psychotropic Drugs in Human Breast Milk, Int. Drug Ther. Newsletter8: 33–40 (Nov.-Dec.) 1973.
78.
FinchE.LorberJ.: Methemoglobinemia in the Newborn Probably Due to Phenytoin Excreted in Human Milk, J. Obstet. Gynaecol. Br. Emp.61: 833–834 (Dec.) 1954.
79.
SvensmarkO.: 5,5-Diphenylhydantoin (Dilantin®) Blood Levels after Oral or Intravenous Dosage in Man, Acta Pharmacol. Toxicol.16: 331–346, 1960.
80.
MayoC. C.SchlickeC. P.: Appearance of a Barbiturate in Human Milk, Proc. Staff Meet. Mayo Clin.17: 87–88 (Feb. 11) 1942.
81.
HooperJ. H.: Abnormal Lactation Associated with Tranquilizing Drug Therapy, J. Am. Med. Assoc.178: 506–507 (Nov. 4) 1961.
82.
BlackerK. H.: Mother's Milk and Chlorpromazine, Am. J. Psychiatr.119: 178–179 (Aug.) 1962.
83.
SchouM.AmdisenA.: Lithium and Pregnancy — III, Lithium Ingestion by Children Breast-Fed by Women on Lithium Treatment, Br. Med. J.2: 138 (Apr. 21) 1973.
84.
TunnessenW. W.HertzC. G.: Toxic Effects of Lithium in Newborn Infants: A Commentary, J. Pediatr.81: 804–807 (Oct.) 1972.
WerthmannM. W.KreesS. V.: Excretion of Chlorothiazide in Human Breast Milk, J. Pediatr.81: 781–783 (Oct.) 1972.
87.
BaldwinW. F.: Clinical Study of Senna Administration to Nursing Mothers: Assessment of Effects on Infant Bowel Habits, Can. Med. Assoc. J.89: 566–568 (Sept. 14) 1963.
88.
TysonR. M.: Drugs Transmitted through Breast Milk, Part I. Laxatives, J. Pediatr.11: 824–832 (Dec.) 1937.
89.
SousaP. L. R.: Metoclopramide and Breast-Feeding, Br. Med. J.1: 512 (Mar. 1) 1975.
90.
FantusB.DyniewiczJ. M.: Phenolphthalein Administration to Nursing Women, Am. J. Dig. Dis. Nutr.3: 184–185 (May) 1936.
91.
WerthmannM. W.KreesS. V.: Quantitative Excretion of Senokot in Human Breast Milk, Med. Ann. D.C.42: 4–5 (Jan.) 1973.
92.
Llewellyn-JonesD.: Inhibition of Lactation, Drugs10: 121–129, 1975.
93.
VorherrH.: Contraception after Abortion and Post Partum, Am. J. Obstet. Gynecol.117: 1002–1025 (Dec. 1) 1973.
SammourM. B.: Effect of Chlormadinone on the Composition of Human Milk, Fertil. Steril.24: 301–304 (Apr.) 1973.
98.
ToaffR.: Effects of Oestrogen and Progestagen on the Composition of Human Milk, J. Reprod. Fertil.19: 475–482 (Aug.) 1969.
99.
KaderM. M. A.: Clinical, Biochemical and Experimental Studies on Lactation III. Biochemical Changes Induced in Human Milk by Gestagens, Am. J. Obstet. Gynecol.105: 978–985 (Nov. 15) 1969.
100.
CurtisE. M.: Oral-Contraceptive Feminization of a Normal Male Infant, Obstet. Gynecol.23: 295–296 (Feb.) 1964.
101.
MarriqP.OddoG.: La Gynécomastie Induite Chez le Nouveau-Né par le Lait Maternel?, Nouv. Presse Méd.3: 2579 (Nov. 30-Dec. 14) 1974.
102.
LauritzenC.: On Endocrine Effects of Oral Contraceptives, Acta Endocrinol.124 (supp.): 87–100, 1967.
103.
WongY. K.WoodB. S. B.: Breast-Milk Jaundice and Oral Contraceptives, Br. Med. J.4: 403–404 (Nov. 13) 1971.
104.
GouldS. R.: Influence of Previous Oral Contraception and Maternal Oxytocin Infusion on Neonatal Jaundice, Br. Med. J.3: 228–230 (July 27) 1974.
105.
PincusG.: Radioactivity in the Milk of Subjects Receiving Radioactive 19-Norsteroids, Nature212: 924–925 (Nov. 26) 1966.
106.
WijmengaH. G.van der MolenH. J.: Studies with 4-14C-Mestranol in Lactating Women, Acta Endocrinol.61: 665–677 (Aug.) 1969.
107.
LaumasK. R.: Radioactivity in the Breast Milk of Lactating Women After Oral Administration of 3H-Norethynodrel, Am. J. Obstet. Gynecol.98: 411–413 (June 1) 1967.
108.
LaumasV.: The Possibility of Estrogenic Activity in the Human and Goat Milk after Administration of Oral Gestagens, Contraception2: 331–338 (Nov.) 1970.
109.
McKenzieS. A.: Secretion of Prednisolone into Breast Milk, Arch. Dis. Child.50: 894–896 (Nov.) 1975.
110.
KatzF. H.DuncanB. R.: Entry of Prednisone into Human Milk, N. Engl. J. Med.293: 1154 (Nov. 27) 1975.
111.
AriasI. M.: Prolonged Neonatal Unconjugated Hyperbilirubinemia Associated with Breast Feeding and a Steroid, Pregnane-3(alpha), 20(beta)-Diol, in Maternal Milk that Inhibits Glucuronide Formation In Vitro, J. Clin. Invest.43: 2037–2047 (Nov.) 1964.
112.
AriasI. M.GartnerL. M.: Jaundice in Breast-Fed Neonates, J. Am. Med. Assoc.218: 746 (Nov. 1) 1971.
113.
FoliotA.: Breast Milk Jaundice: In Vitro Inhibition of Rat Liver Bilirubin-Uridine Diphosphate Glucuronyltransferase Activity and Z Protein-Bromosulfophthalein Binding by Human Breast Milk, Pediatr. Res.10: 594–598, 1976.
114.
WilliamsR. H.: Thiouracil. Its Absorption, Distribution, and Excretion, J. Clin. Invest.23: 613–627 (Sept.) 1944.
115.
MoielR. H.RyanJ. R.: Tolbutamide Orinase in Human Breast Milk, Clin. Pediatr.8: 480 (Aug.) 1967.
116.
LarsonS. M.SchallG. L.: Gallium 67 Concentration in Human Breast Milk, J. Am. Med. Assoc.218: 257 (Oct. 11) 1971.
117.
BlandE. P.: Radioactive Iodine Uptake by Thyroid of Breast-Fed Infants after Maternal Blood-Volume Measurements, Lancet2: 1039–1041 (Nov. 15) 1969.
118.
NurenbergerC. E.LipscombA.: Transmission of Radioiodine (I131) to Infants Through Human Maternal Milk, J. Am. Med. Assoc.150: 1398–1400 (Dec. 6) 1952.
119.
WeaverJ. C.: Excretion of Radioiodine in Human Milk, J. Am. Med. Assoc.173: 872–875 (June 25) 1960.
120.
MillerH.WeetchR. S.: The Excretion of Radioactive Iodine in Human Milk, Lancet2: 1013 (Nov. 12) 1955.
121.
WyburnJ. R.: Human Breast Milk Excretion of Radionuclides Following Administration of Radiopharmaceuticals, J. Nucl. Med.14: 115–117 (Feb.) 1973.
122.
SchwartzK.-D.: The Excretion of I131 in Breast Milk in Isotope Nephrography Performed with I131- Hippurate Post Partum, Rad. Biol. Ther.9: 259–262 (July) 1968.
123.
SpencerR. P.: Breast Secretion of 99mTc in the Amenorrhea-Galactorrhea Syndrome, J. Nucl. Med.11: 467 (July) 1970.
124.
VagenakisA. G.: Duration of Radioactivity in the Milk of a Nursing Mother Following 99mTc Administration, J. Nucl. Med.12: 188 (Apr.) 1971.
125.
BerkeR. A.: Radiation Dose to Breast-Feeding Child after Mother Has 99mTc-MAA Lung Scan, J. Nucl. Med.14: 51–52 (Jan.) 1973.
126.
DonnallyH. H.: The Question of the Elimination of Foreign Protein (Egg White) in Women's Milk, J. Aller.1: 78 (Nov.) 1929.
127.
BercoviciB.: Fluorine in Human Milk, Obstet. Gynecol.16: 319–321 (Sept.) 1960.
128.
EricssonY.: Fluoride Excretion in Human Saliva and Milk, Caries Res.3: 159–166, 1969.
129.
EricssonY.: Pilot Studies on the Fluoride Metabolism in Infants on Different Feedings, Acta Pediatr. Scand.61: 459–464 (July) 1972.
130.
RamasastriB. V.: Folate Activity in Human Milk, Br. J. Nutr.19: 581–586, 1965.
131.
MetzJ.: Folic Acid Binding by Serum and Milk, Am. J. Clin. Nutr.21: 289–297 (Apr.) 1968.
132.
SteginkL. D.: Monosodium Glutamate: Effect on Plasma and Breast Milk Amino Acid Levels in Lactating Women, Proc. Soc. Exper. Biol. Med.140: 836–841 (July) 1972.
133.
DeodharA. D.: Effect of Socioeconomic Status on the Vitamin Content of Milk, J. Pediatr.54: 34–35 (Jan.) 1959.
134.
FoukasM. D.: An Antilactogenic Effect of Pyridoxine, J. Obstet. Gynaecol. Br. Commonw.80: 718–720 (Aug.) 1973.
135.
MacdonaldH. N.: The Failure of Pyridoxine in Suppression of Puerperal Lactation, Br. J. Obstet. Gynaecol.83: 54–55 (Jan.) 1976.
136.
CanalesE. S.: The Influence of Pyridoxine on Prolactin Secretion and Milk Production in Women, Br. J. Obstet. Gynaecol.83: 387–388 (May) 1976.
137.
FehilyL.: Human-Milk Intoxication Due to B1 Avitaminosis, Br. Med. J.2: 590–592 (Nov. 4) 1944.
138.
CollinsR. A.: The Folic Acid and Vitamin B12 Content of the Milk of Various Species, J. Nutr.43: 313–321 (Feb. 10) 1951.
139.
GoldbergL. D.: Transmission of a Vitamin-D Metabolite in Breast Milk, Lancet2: 1258–1259 (Dec. 9) 1972.
140.
DyggveH. V.: Influence on the Prothrombin Time of Breast-Fed Newborn Babies of One Single Dose of Vitamin K1 or Synkavit (sic) Given to the Mother Within 2 Hours After Birth, Acta Obstet. Gynaecol. Scand.35: 440–444, 1956.
141.
del ReR. B.: Prolactin Inhibition and Suppression of Puerperal Lactation by a Br-Ergocryptine (CB 154), Obstet. Gynecol.41: 884–890 (June) 1973.
142.
UtianW. H.: Effect of Bromocriptine and Chlorotrianisene on Inhibition of Lactation and Serum Prolactin: A Comparative Double-Blind Study, Br. J. Obstet. Gynaecol.82: 755–759 (Sept.) 1959.
143.
ShaneJ. M.NaftolinF.: Effect of Ergonovine Maleate on Puerperal Prolactin, Am. J. Obstet. Gynecol.120: 129–131 (Sept.) 1974.
144.
FlossH. G.: Influence of Ergot Alkaloids on Pituitary Prolactin and Prolactin-Dependent Processes, J. Pharm. Sci.62: 699–715 (May) 1973.
145.
BlauS. P.: Metabolism of Gold During Lactation, Arth. Rheum.16: 777–778 (Nov.-Dec.) 1973.
146.
HolmdahlK. H.: Cholecystography During Lactation, Acta Radiol.45: 305–307 (Apr.) 1956.
147.
del PozoE.: Lack of Effect of Methyl-Ergonovine on Postpartum Lactation, Am. J. Obstet. Gynecol.123: 845–846 (Dec. 15) 1975.
148.
LuhmanL. A.: The Effect of Intranasal Oxytocin on Lactation, Obstet. Gynecol.21: 713–717 (June) 1963.
149.
Report of the Committee on Infectious Diseases, 17th Ed., American Academy of Pediatrics, Evanston, Ill., 1974, pp. 54–55.
150.
WarrenR. J.: The Relationship of Maternal Antibody, Breast Feeding and Age to the Susceptibility of Newborn Infants to Infection with Attenuated Polioviruses, Pediatrics34: 4–13 (July) 1964.
151.
DeforestA.: The Effect of Breast-Feeding on the Antibody Response of Infants to Trivalent Oral Poliovirus Vaccine, J. Pediatr.83: 93–95 (July) 1973.
152.
JohnT. J.: Effect of Breast-Feeding on Seroresponse of Infants to Oral Poliovirus Vaccination, Pediatrics57: 47–53 (Jan.) 1976.
153.
LevitanA. A.ManionJ. C.: Propranolol Therapy During Pregnancy and Lactation, Am. J. Cardiol.32: 247 (Aug.) 1973.
154.
AndersonP. O.SalterF. J.: Propranolol Therapy During Pregnancy and Lactation, Am. J. Cardiol.37: 325 (Feb.) 1976.
155.
KarlbergB.: Excretion of Propranolol in Human Breast Milk, Acta Pharmacol. Toxicol.34: 222–224 (Mar.) 1974.
156.
FarquharJ. D.: Follow-Up on Rubella Vaccinations and Experience with Subclinical Reinfection, J. Pediatr.81: 460–465 (Sept.) 1972.
157.
YurchakA. M.JuskoW. J.: Theophylline Secretion into Breast Milk, Pediatrics57: 518–520 (Apr.) 1976.
158.
ÅarkrogA.: Caesium-137 From Fall-Out in Human Milk, Nature197: 667–668 (Feb. 16) 1963.
159.
CalapajG. G.OngaroD.: Sul “Rapporto Osservato” Sr90/Ca e Cs137/K Fra Dieta e Latte Umano, Nuovi Ann. Microbiol.18: 383–394 (Sept.-Oct.) 1967.
160.
WoodardB. T.: DDT Levels in Milk of Rural Indigent Blacks, Am. J. Dis. Child.130: 400–403 (Apr.) 1976.
161.
LuquetF.-M.: Pollution of Human Milk in France with Organochlorine Insecticide Residues, Pathol. Biol. (Paris)23: 45–49 (Jan.) 1975.
162.
ÇamC.: Une Nouvelle Dermatose Épidémique des Enfants, Ann. Dermatol. Syphilig.87: 393–397 (July-Aug.) 1960.
163.
WestR. W.: Hexachlorophene Concentrations in Human Milk, Bull. Environ. Contam. Toxicol.13: 167–169 (Feb.) 1975.
164.
DillonH. K.: Lead Concentrations in Human Milk, Am. J. Dis. Child.128: 491–492 (Oct.) 1974.
165.
HatcherR. A.CrosbyH.: The Elimination of Nicotin (sic) in the Milk, J. Pharmacol. Exper. Ther.32: 1–6 (Nov.) 1927.
166.
PerlmanH. H.: The Excretion of Nicotine in Breast Milk and Urine From Cigaret Smoking, J. Am. Med. Assoc.120: 1003–1009 (Nov. 28) 1942.
167.
PommerenkeW. T.HahnP. F.: Secretion of Radio-active Sodium in Human Milk, Proc. Soc. Exper. Biol. Med.52: 223–224 (Mar.) 1943.
168.
JarvisA. A.: Strontium-89 and Strontium-90 Levels in Breast Milk and in Mineral-Supplement Preparations, Can. Med. Assoc. J.88: 136–139 (Jan. 19) 1963.
169.
StraubC. P.MurthyG. K.: A Comparison of Sr90 Component of Human and Cows' Milk, Pediatrics36: 732–735 (Nov.) 1965.
170.
Anon.: Metronidazole Box Warning, FDA Drug Bull.6: 22–23 (Apr.-May) 1976.
171.
BatyJ. D.: May Mothers Taking Warfarin Breast Feed their Infants?, Br. J. Clin. Pharmacol.3: 969 (Oct.) 1976.